...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith - Question regarding NR..

,,,,,,hummmmmm,,,,,,,agreed,,,,,I would think where one company is public and one is private,,the public company to comply with the securities law would be required to air all information to their shareholders in a news release. Possibly they did and no reader would know Zenith from a whole in the ground,,,,,,,why Zenith wouldnt see the news as a feather in their hat is a head scratcher,,,that is if they do know,,,,!

Share
New Message
Please login to post a reply